Skip to main content
ECOR
NASDAQ Life Sciences

Record $9.6M Q1 Revenue for electroCore, Adjusted EBITDA Loss Narrows to $2.3M

feedReported by Wiseek News
Sentiment info
Positive
Importance info
8
Price
$7
Mkt Cap
$53.836M
52W Low
$4.16
52W High
$8.64
Market data snapshot near publication time

summarizeSummary

electroCore reported record first-quarter 2026 net sales of $9.6 million, marking a 43% year-over-year increase, and significantly narrowed its adjusted EBITDA loss to $2.3 million from $3.1 million a year prior. This positive financial update, which also highlighted an improved gross margin of 87%, comes after the company disclosed substantial doubt about its ability to continue as a going concern in its recent 10-K filing. The strong revenue growth, driven by its VA channel and Quell product line, and reduced losses are crucial in addressing these prior financial viability concerns. Investors will be closely watching for sustained operational improvements and continued progress towards profitability, especially as the company reiterates its full-year 2026 revenue guidance of approximately 30% growth.

At the time of this announcement, ECOR was trading at $7.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53.8M. The 52-week trading range was $4.16 to $8.64. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed ECOR - Latest Insights

ECOR
May 06, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
8
ECOR
May 06, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
ECOR
May 06, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
ECOR
May 05, 2026, 10:37 AM EDT
Filing Type: 144
Importance Score:
8
ECOR
Mar 19, 2026, 4:35 PM EDT
Filing Type: 10-K
Importance Score:
9
ECOR
Mar 19, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
ECOR
Jan 20, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7